ESC 365 - The mitral valve in patients with AF and HF - Do we need specific therapy?

EHRA Premium Access

The mitral valve in patients with AF and HF - Do we need specific therapy?

Session: New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Topic: Heart Failure and Left Ventricular Dysfunction

Speaker: Professor R. Rosenhek (Vienna, AT)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Professor Raphael Rosenhek

Medical University of Vienna, Vienna (Austria)

27 presentations

2 followers

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Stewart Coats (Sydney, AU)

Is there a role for anti-arrhythmic drugs or catheter ablation?

Speaker: Professor F. Ruschitzka (Zurich, CH)

Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

Speaker: Professor D. Kotecha (Birmingham, GB)

Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor R. Rosenhek, Professor A. Stewart Coats, Professor F. Ruschitzka, Professor D. Kotecha

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources